Key statistics
On Friday, Veracyte Inc (12V:FRA) closed at 20.60, 8.42% above its 52-week low of 19.00, set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.60 |
---|---|
High | 20.60 |
Low | 20.60 |
Bid | 20.20 |
Offer | 20.40 |
Previous close | 22.00 |
Average volume | 560.80 |
---|---|
Shares outstanding | 78.31m |
Free float | 76.90m |
P/E (TTM) | 57.82 |
Market cap | 1.90bn USD |
EPS (TTM) | 0.4189 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 07:10 BST.
More ▼
Press releases
- Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025
- Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025
- Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
- Veracyte to Participate in Upcoming Investor Conferences
- Veracyte Announces First Quarter 2025 Financial Results
- Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
- Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
- Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
More ▼